Novazyme Pharmaceuticals Inc.

The Biotechnology Innovation Organization’s new president and CEO John Crowley brings to the role more than two decades of experience in the biotech drug industry and a strong history of rare disease

President Trump, in his first speech to a joint session Congress Feb. 28, criticized FDA's approval process as a barrier to new medical innovations. In the context of praising a young woman, Megan Cro

President Trump offered an uplifting story about drug approvals during his Feb. 28 address at a joint session of Congress, but unfortunately for FDA, it was the villain in the piece, with "burdensome"

In VitroDiagnostic Transactions In this issue we are presenting our quarterly review of dealmaking for July-September 2001. Our data comes from Windhover's Strategic Transactions Database , which cov